| Literature DB >> 32355876 |
Dhruvil Radadiya1, Alexei Gonzalez-Estrada2, Jorge Emilio Lira-Vera3, Katia Lizarrga-Torres4, Shayan Sinha Mahapatra5, Ricardo Murguia-Fuentes6, Sebastian Niezen7, Kaushik Mohan8, Chakradhar Reddy9, Kalpit Devani9.
Abstract
Background and study aims Colonoscopy is an effective tool to prevent colorectal cancer. Social media has emerged as a source of medical information for patients.YouTube (a video sharing website) is the most popular video informative source. Therefore, we aimed to assess the educational quality of colonoscopy videos available on YouTube. Methods We performed a YouTube search using the keyword "colonoscopy" yielded 429 videos, of which 255 met the inclusion criteria. Colonoscopy Data Quality Score (C-DQS) was created to rate the quality of the videos (-10 to +40 points) based on a colonoscopy education video available on the Ameican Society of Gastrointestinal Endoscopy (ASGE) website. Each video was scored by six blinded reviewers independently using C-DQS. The Global Quality Score (GQS) was used for score validation. The intraclass correlation coefficient (ICC) was used to assess the similarity of the scores among reviewers. Results Professional societies had the highest number of videos (44.3 %). Videos from professional societies (6.94) and media (6.87) had significantly higher mean C-DQS compared to those from alternative medicine providers (1.19), companies (1.16), and patients (2.60) ( P < 0.05). Mean C-DQS score of videos from healthcare providers (4.40) was not statistically different than other sources. There was a high degree of agreement among reviewers for the videos from all sources (ICC = 0.934; P < 0.001). Discussion YouTube videos are a poor source of information on colonoscopy. Professional societies and media are better sources of quality information for patient education on colonoscopy. The medical community may need to engage actively in enriching the quality of educational material available on YouTube.Entities:
Year: 2020 PMID: 32355876 PMCID: PMC7165015 DOI: 10.1055/a-1122-8566
Source DB: PubMed Journal: Endosc Int Open ISSN: 2196-9736
Fig. 1 Study design.
Colonoscopy Data Quality Score (C-DQS).
| Defines colonoscopy (1 point) e. g., colonoscopy is the procedure to look at large bowel, and it is a safe and effective procedure. |
| Mentions that colonoscopy is currently the best screening method for preventing colon cancer (1 point) |
| States prevalence of screening colonoscopy (1 point) e. g., the number of colonoscopies performed 14.2 million per year in the USA |
| Defines colonoscope (1 point) It is a flexible tube with a small camera and light at the end, which allows the examination of the colon. |
| Indications for colonoscopy as a diagnostic and therapeutic procedure (1 point each, maximum 5 points) |
| Colon cancer |
| Polyps |
| Hemorrhoids |
| IBD |
| Large intestinal disorders |
| Gives an estimate of colon cancer risk over the lifetime (1 point) e. g., Every individual has a 6 % risk of developing colon cancer over a lifetime. |
| Mentions that Colonoscopy helps to prevent cancer by removing polyps before they turn into cancer (1 point) |
| Mentions that colonoscopy is the only test which can find and remove polyp at the same time among colon cancer screening tests (1 point) |
|
|
| Mentions that the patient will be given written preparation instructions before the procedure (1 point) |
| Describes Bowel preparation regimen (1 point) e. g., Cleansing begins before the day of the exam, and there are different types of bowel prep |
| Mentions that clear liquid one day before the procedure should be followed (1 point) |
| Emphasizes the importance of good bowel prep better colon visualization and avoid cancellation (1 point) e. g., proper bowel prep means the quicker, safer, more comfortable, and more effective procedure. |
| Recommends no eating or drinking 6 hours before the procedure (1 point) |
| Describes that doctor will advise withholding certain medication before the procedure (1 point) |
| Encourages patients to ask a question to the medical team if needed (1 point) |
|
|
| Mentions that Informed consent will be obtained after explaining risk, benefits, and alternatives (1 point) |
| Mentions that Procedure will be performed under sedation (1 point) |
| Mentions that for sedation Iv access will be obtained (1 point) |
| Describes procedure in general (1 point) e. g. Colonoscopy is done in a procedure room equipped with colonoscope and TV screen to see images of the colon. |
| Describes colonoscope and how does it work (1 point) e. g. Flexible tube with camera and light source at the end with a channel to pass instruments for biopsy. The scope has dials to maneuver in a different direction. The scope will be passed to the cecum. |
| Describes what endoscopist looking for during procedure (1 point) e. g., Polyps, source of bleeding, inflammation, etc. |
| Mentions that the duration of colonoscopy is usually less than an hour (1 point) |
| Mentions that colonoscopy is a well-tolerated procedure (1 point) |
| Describes complications of the procedure(1 point each, maximum of 4 points) |
| Perforation |
| bleeding |
| missing polyp or lesion |
| adverse drug reaction |
| Defines polyp and/or types of polyp (1 point) |
|
|
| Mentions that the patient will be closely watched for 30 mins after the procedure (1 point) |
| Mentions that patient will be made aware of preliminary results, new medications and follow up plan (1 point) |
| Mentions that Mild bloating and gas expected after the procedure (1 point) |
| Mentions what is the biopsy and states that biopsy results can take several days and how to follow up (1 point) |
| Mentions that the patient should not go to work or drive or handle heavy machinery on the same day (1 point) |
| Mentions that the patient will need somebody to drive him/her back home (1 point) |
| Mentions that the patient can return to normal activity the next day following the procedure (1 point) |
| Advises the patient to call a doctor if the patient has abdominal pain, bleeding or fever (1 point) |
|
|
|
|
| Colonoscopy is useless procedure. |
| Colonoscopy increases risk of colon cancer. |
| Colonoscopy does not prevent colon cancer. |
| Colonoscopy does not have any supporting scientific evidence. |
| Colonoscopy should not be performed in asymptomatic patients. |
| Colonoscopy is a high-risk procedure with a high mortality rate and complication rate. |
| Colonoscopy is an expensive procedure. |
| Colonoscopy is performed without sedation and very uncomfortable. |
| Bowel preparation is not needed before colonoscopy. |
| Colonoscopy is a solely diagnostic procedure. |
|
|
Global Quality Score (GQS).
| 1 | Poor quality, poor flow of the site, most information missing, not at all useful for patients |
| 2 | Generally poor quality and poor flow, some information listed but many important topics missing, of minimal use to patients |
| 3 | Moderate quality, suboptimal flow, some important information is adequately discussed, but others poorly explained, somewhat useful for patients |
| 4 | Good quality and generally good flow. Most of the relevant information is listed, but some topics not covered, useful for patients |
| 5 | Excellent quality and flow, beneficial for patients |
Colonoscopy video characteristics.
| Variable | N = 255 |
| Sex depicted, no. (%) | |
Male | 114 (44.7) |
Female | 98 (38.4) |
Both | 40 (17.3) |
| Race Depicted, no. (%) | |
White | 168 (62.5) |
African-American | 20 (7.4) |
Hispanic | 5 (1.9) |
Asian | 39 (14.5) |
None | 37 (13.8) |
| Median no. views | 5503 |
| Median no. likes | 11 |
| Median no. dislikes | 1 |
| Median no. comments | 1 |
| Median duration, seconds | 236 |
Top 10 videos by C-DQS.
| Rank | Video Link | Video Source | Video Source Type | Number of likes | Duration (min:sec) | Mean C-DQS |
| 1 |
| The American Society for Gastrointestinal Endoscopy | Professional society | 253 | 10:08 | 40 |
| 2 |
| UW Medicine, Division of Gastroenterology | Professional society | 218 | 18:19 | 26.1 |
| 3 |
| Lourdes Health and Medical Center | Professional Society | 4 | 10:05 | 24.6 |
| 4 |
| CDHFtube by Dr. Alan Barkun | Health care provider | 9 | 12:09 | 23.3 |
| 5 |
| AGA Institute | Professional society | 576 | 10:03 | 22.8 |
| 6 |
| NorthShore University HealthSystem | Professional society | 69 | 6:34 | 20.6 |
| 6 |
| Bumrungrad International Hospital | Professional society | 6 | 6:15 | 20.6 |
| 7 |
|
| Media | 1580 | 5:14 | 19.1 |
| 8 |
| South West Regional Cancer Program | Professional society | 0 | 9:30 | 18.1 |
| 9 |
| MD Anderson Cancer Center | Professional society | 193 | 8:07 | 18 |
| 9 |
| Vancouver Coastal Health | Professional society | 0 | 8:35 | 18 |
| 10 |
| Easy Health | Media | 12 | 10:54 | 16.8 |
C-DQS, colonoscopy data quality score
Fig. 2 Correlation between mean C-DQS and GQS.
Difference between mean C-DQS and mean GQS among video sources.
| Video source |
Mean C-DQS
|
Grouping
|
Mean GQS
|
Grouping
|
| Professional society | 6.94 | a | 2.40 | a |
| Media | 6.87 | a | 2.31 | a |
| Healthcare provider | 4.40 | ab | 2.03 | b |
| Patient and/or patient parents | 2.60 | b | 1.43 | b |
| Alternative medicine provider | 1.19 | b | 1.39 | b |
| Company | 1.16 | b | 1.25 | b |
C-DQS, colonoscopy data quality score; GQS, global quality score
One-way ANOVA showed that mean GQS, and C-DQS among sources were not same ( P < 0.0001)
Grouping of source based on fisher’s test of least significance (significance set at P < 0.05). Each same lower case letter shows that there is no difference in mean C-DQS/GQS between two sources with same letter. Two lowercase letters assigned to a source suggest the no difference in mean score with either of group represented by individual letter.
Mean colonoscopy data quality score by video source.
| Video source | Mean | ICC | Confidence Interval |
| N |
| All sources | 5.38 | 0.934 | 0.908–0.951 | < 0.001 | 255 |
| Professional society (e. g., hospital, organization, healthcare society) | 6.94 | 0.933 | 0.894–0.956 | < 0.001 | 113 |
| Media (e. g., news channel) | 6.87 | 0.922 | 0.863–0.956 | < 0.001 | 47 |
| Health care provider (e. g., physician) | 4.40 | 0.946 | 0.904–0.974 | < 0.001 | 24 |
| Patient and/or patient’s parents | 2.60 | 0.859 | 0.788–0.912 | < 0.001 | 53 |
| Company (e. g., pharmaceutical company) | 1.16 | 0.546 | 0.003–0.848 | 0.026 | 12 |
| Alternative medicine provider | 1.19 | 0.840 | 0.487–0.975 | 0.001 | 6 |
ICC, intraclass correlation co-efficient; N, number of videos